FACIT and Triphase Accelerator announced a new strategic collaboration with Celgene for a first-in-class pre-clinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia.
FACIT and Triphase Accelerator Announce New Partnership with Celgene
Previous
Previous
TopSpin Technologies Wins NFL Pitch Competition
Next
Next